Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abbott, K. C.
Right arrow Articles by Agodoa, L. Y. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abbott, K. C.
Right arrow Articles by Agodoa, L. Y. C.
J Am Soc Nephrol 14:2358-2365, 2003
© 2003 American Society of Nephrology

Early Renal Insufficiency and Hospitalized Heart Disease after Renal Transplantation in the Era of Modern Immunosuppression

Kevin C. Abbott*, Christina M. Yuan*, Allen J. Taylor{dagger}, David F. Cruess{ddagger} and Lawrence Y. C. Agodoa§

*Nephrology Service, Walter Reed Army Medical Center, Washington, DC, and Uniformed Services University of the Health Sciences, Bethesda, Maryland; {dagger}Cardiology Service, Walter Reed Army Medical Center, Washington, DC; {ddagger}Department of Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences, Bethesda, Maryland; and §National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.

Correspondence to Dr. Kevin C. Abbott, Nephrology Service, Walter Reed Army Medical Center, Washington, DC 20307-5001. Phone: 202-782-6462/6463/6288; Fax: 202-782-0185;

ABSTRACT. Renal insufficiency has been identified as a risk factor for graft loss and death after renal transplantation but has not been consistently linked to early, nonfatal, hospitalized heart disease (HHD). With the United States Renal Data System database, 29,597 patients who received a kidney transplant between January 1, 1996, and July 31, 2000, with Medicare as the primary payer, and were monitored until December 31, 2000, were studied. Cox proportional-hazards regression models were used to calculate the association of recipient estimated GFR (eGFR) at 1 yr after renal transplantation, as determined with the Modification of Diet in Renal Disease formula, with hospitalization for treatment of acute coronary syndromes (ACS) (International Classification of Diseases, version 9, code 410.x or 411.x) or congestive heart failure (CHF) (code 428.x) 1 to 3 yr after renal transplantation. Rates of ACS and CHF were 2.2 and 4.9%, respectively, for patients with eGFR of <44.8 ml/min per 1.73 m2, compared with 1.2 and 1.4% for patients with eGFR of >69.7 ml/min per 1.73 m2. Reduced eGFR (<44.8 ml/min per 1.73 m2, compared with >69.7 ml/min per 1.73 m2) at the end of the first 1 yr after transplantation was independently associated with increased risks of both ACS (adjusted hazard ratio, 2.16; 95% confidence interval, 1.39 to 3.35) and CHF (adjusted hazard ratio, 2.95; 95% confidence interval, 2.24 to 3.90). It was concluded that early renal insufficiency (approximately stage 3 chronic kidney disease) was associated with higher rates of HHD 1 to 3 yr after kidney transplantation. Preservation of renal function after renal transplantation may reduce the rates of HHD, and renal transplant recipients with reduced eGFR should be considered at high risk of developing cardiovascular disease. E-mail: kevin.abbott@na.amedd.army.mil




This article has been cited by other articles:


Home page
CJASNHome page
K. L. Lentine, L. A. R. Rey, S. Kolli, G. Bacchi, M. A. Schnitzler, K. C. Abbott, H. Xiao, and D. C. Brennan
Variations in the Risk for Cerebrovascular Events after Kidney Transplant Compared with Experience on the Waiting List and after Graft Failure
Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1090 - 1101.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
K. L. Lentine, M. A. Schnitzler, D. C. Brennan, J. J. Snyder, P. J. Hauptman, K. C. Abbott, D. Axelrod, P. R. Salvalaggio, and B. Kasiske
Cardiac Evaluation before Kidney Transplantation: A Practice Patterns Analysis in Medicare-insured Dialysis Patients
Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1115 - 1124.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. Borrows, M. Loucaidou, G. Chusney, S. Borrows, J. V. Tromp, T. Cairns, M. Griffith, N. Hakim, A. McLean, A. Palmer, et al.
Anaemia and congestive heart failure early post-renal transplantation
Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1728 - 1734.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
K. L. Lentine, M. A. Schnitzler, K. C. Abbott, L. Li, H. Xiao, T. E. Burroughs, S. K. Takemoto, L. M. Willoughby, J. A. Gavard, and D. C. Brennan
Incidence, Predictors, and Associated Outcomes of Atrial Fibrillation after Kidney Transplantation
Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 288 - 296.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. L. Kasiske, J. R. Maclean, and J. J. Snyder
Acute Myocardial Infarction and Kidney Transplantation
J. Am. Soc. Nephrol., March 1, 2006; 17(3): 900 - 907.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. Vanholder, Z. Massy, A. Argiles, G. Spasovski, F. Verbeke, N. Lameire, and for the European Uremic Toxin Work Group (EUTox)
Chronic kidney disease as cause of cardiovascular morbidity and mortality
Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1048 - 1056.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. L. Lentine, D. C. Brennan, and M. A. Schnitzler
Incidence and Predictors of Myocardial Infarction after Kidney Transplantation
J. Am. Soc. Nephrol., February 1, 2005; 16(2): 496 - 506.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
K. C. Abbott, F. C. Trespalacios, L. Y. Agodoa, A. J. Taylor, and G. L. Bakris
{beta}-Blocker Use in Long-term Dialysis Patients: Association With Hospitalized Heart Failure and Mortality
Arch Intern Med, December 13, 2004; 164(22): 2465 - 2471.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. C. Abbott, K. L. Lentine, J. R. Bucci, L. Y. Agodoa, J. M. Koff, K. C. Holtzmuller, and M. A. Schnitzler
Impact of Diabetes and Hepatitis after Kidney Transplantation on Patients Who Are Affected by Hepatitis C Virus
J. Am. Soc. Nephrol., December 1, 2004; 15(12): 3166 - 3174.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP